1417736-94-7

Basic information

• Product Name: rac-methyl 4-{4-amino-7-[cyclopropyl(hydroxy)methyl]pyrrolo[2,1-f][1,2,4]triazin-5-yl}-2-methoxybenzoate
• Synonyms: rac-methyl 4-{4-amino-7-[cyclopropyl(hydroxy)methyl]pyrrolo[2,1-f][1,2,4]triazin-5-yl}-2-methoxybenzoate
• CAS NO: 1417736-94-7
• Molecular Weight: 368.392
• Mol File: 1417736-94-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: rac-methyl 4-{4-amino-7-[cyclopropyl(hydroxy)methyl]pyrrolo[2,1-f][1,2,4]triazin-5-yl}-2-methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: rac-methyl 4-{4-amino-7-[cyclopropyl(hydroxy)methyl]pyrrolo[2,1-f][1,2,4]triazin-5-yl}-2-methoxybenzoate(1417736-94-7)
• EPA Substance Registry System: rac-methyl 4-{4-amino-7-[cyclopropyl(hydroxy)methyl]pyrrolo[2,1-f][1,2,4]triazin-5-yl}-2-methoxybenzoate(1417736-94-7)

Safety Data

• Hazardous Substances Data: 1417736-94-7(Hazardous Substances Data)

Upstream product

• 1369350-92-4 4-amino-5-bromopyrrolo [2,1-f][1,2,4]triazine-7-carbaldehyde 
• 159326-68-8 pyrrolo[2,1-f][1,2,4]triazin-4-amine 
• 939967-94-9 4-aminopyrrolo[2,1-f][1,2,4]triazine-7-carbaldehyde 
• 603122-41-4 (3-methoxy-4-(methoxycarbonyl)phenyl)boronic acid 
• 1417736-47-0 (4-amino-5-bromopyrrolo[2,1-f][1,2,4]triazin-7-yl)(cyclopropyl)methanol 

Downstream Products

• 1417736-38-9 rac-{4-amino-5-[4-(hydroxymethyl)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}(cyclopropyl)methanol 
• 1417736-39-0 {4-amino-5-[4-(hydroxymethyl)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}(cyclopropyl)methanol 
• 1417736-40-3 {4-amino-5-[4-(hydroxymethyl)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}(cyclopropyl)methanol 

Relevant articles and documents

HYDROXYMETHYLARYL-SUBSTITUTED PYRROLOTRIAZINES AS ALK1 INHIBITORS

This invention relates to novel 5-[(hydroxymethyl)aryl] -substituted pyrrolo[2, 1-f][1, 2, 4] triazin-4-amines of formula (I), to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating angiogenesis-related disorders, in particular angiogenesis-related ocular disorders.